Annual Total Long Term Liabilities
$2.01 M
-$3.56 M-63.93%
01 December 2023
Summary:
Plus Therapeutics annual total long term liabilities is currently $2.01 million, with the most recent change of -$3.56 million (-63.93%) on 01 December 2023. During the last 3 years, it has risen by +$1.47 million (+275.51%). PSTV annual total long term liabilities is now -94.05% below its all-time high of $33.77 million, reached on 31 December 2011.PSTV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$40.00 K
-$10.00 K-20.00%
01 September 2024
Summary:
Plus Therapeutics quarterly total long term liabilities is currently $40.00 thousand, with the most recent change of -$10.00 thousand (-20.00%) on 01 September 2024. Over the past year, it has dropped by -$1.97 million (-98.01%). PSTV quarterly long term liabilities is now -99.90% below its all-time high of $41.54 million, reached on 31 March 2015.PSTV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -98.0% |
| 3 y3 years | +275.5% | -92.1% |
| 5 y5 years | +66.5% | -99.6% |
PSTV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.9% | +275.5% | -99.3% | at low |
| 5 y | 5 years | -73.5% | +275.5% | -99.6% | at low |
| alltime | all time | -94.0% | -99.9% | at low |
Plus Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.00 K(-20.0%) |
| June 2024 | - | $50.00 K(-15.3%) |
| Mar 2024 | - | $59.00 K(-97.1%) |
| Dec 2023 | $2.01 M(-63.9%) | $2.01 M(+1602.5%) |
| Sept 2023 | - | $118.00 K(-13.2%) |
| June 2023 | - | $136.00 K(-18.1%) |
| Mar 2023 | - | $166.00 K(-97.0%) |
| Dec 2022 | $5.57 M(+5.6%) | $5.57 M(+30.1%) |
| Sept 2022 | - | $4.28 M(-7.4%) |
| June 2022 | - | $4.62 M(-6.7%) |
| Mar 2022 | - | $4.95 M(-6.1%) |
| Dec 2021 | $5.28 M(+886.0%) | $5.28 M(+940.4%) |
| Sept 2021 | - | $507.00 K(-5.2%) |
| June 2021 | - | $535.00 K(+5.3%) |
| Mar 2021 | - | $508.00 K(-5.0%) |
| Dec 2020 | $535.00 K(-92.9%) | $535.00 K(-14.8%) |
| Sept 2020 | - | $628.00 K(-24.4%) |
| June 2020 | - | $831.00 K(-85.9%) |
| Mar 2020 | - | $5.89 M(-22.3%) |
| Dec 2019 | $7.58 M(+528.3%) | $7.58 M(-31.9%) |
| Sept 2019 | - | $11.13 M(+799.6%) |
| June 2019 | - | $1.24 M(-49.8%) |
| Mar 2019 | - | $2.46 M(+104.1%) |
| Dec 2018 | $1.21 M(+500.5%) | $1.21 M(-30.7%) |
| Sept 2018 | - | $1.74 M(+461.9%) |
| June 2018 | - | $310.00 K(+9.5%) |
| Mar 2018 | - | $283.00 K(+40.8%) |
| Dec 2017 | $201.00 K(-98.2%) | $201.00 K(-9.9%) |
| Sept 2017 | - | $223.00 K(-97.2%) |
| June 2017 | - | $8.02 M(-15.8%) |
| Mar 2017 | - | $9.53 M(-14.3%) |
| Dec 2016 | $11.12 M(-34.8%) | $11.12 M(-9.3%) |
| Sept 2016 | - | $12.27 M(-11.6%) |
| June 2016 | - | $13.88 M(-10.4%) |
| Mar 2016 | - | $15.49 M(-9.2%) |
| Dec 2015 | $17.05 M(-40.2%) | $17.05 M(-39.1%) |
| Sept 2015 | - | $28.00 M(-20.1%) |
| June 2015 | - | $35.04 M(-15.6%) |
| Mar 2015 | - | $41.54 M(+45.7%) |
| Dec 2014 | $28.50 M(+18.7%) | $28.50 M(+34.9%) |
| Sept 2014 | - | $21.13 M(+4.0%) |
| June 2014 | - | $20.33 M(-8.4%) |
| Mar 2014 | - | $22.20 M(-7.6%) |
| Dec 2013 | $24.02 M(+25.2%) | $24.02 M(-6.8%) |
| Sept 2013 | - | $25.77 M(-16.0%) |
| June 2013 | - | $30.66 M(+114.2%) |
| Mar 2013 | - | $14.31 M(-25.4%) |
| Dec 2012 | $19.18 M | $19.18 M(-27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $26.39 M(-4.2%) |
| June 2012 | - | $27.55 M(-12.0%) |
| Mar 2012 | - | $31.30 M(-7.3%) |
| Dec 2011 | $33.77 M(+11.6%) | $33.77 M(-9.2%) |
| Sept 2011 | - | $37.20 M(+61.7%) |
| June 2011 | - | $23.00 M(-23.9%) |
| Mar 2011 | - | $30.25 M(-0.0%) |
| Dec 2010 | $30.25 M(+49.6%) | $30.25 M(+3.5%) |
| Sept 2010 | - | $29.24 M(+0.3%) |
| June 2010 | - | $29.16 M(+87.0%) |
| Mar 2010 | - | $15.60 M(-22.9%) |
| Dec 2009 | $20.22 M(-22.8%) | $20.22 M(+2.2%) |
| Sept 2009 | - | $19.79 M(-1.5%) |
| June 2009 | - | $20.09 M(-24.2%) |
| Mar 2009 | - | $26.49 M(+1.1%) |
| Dec 2008 | $26.19 M(+14.7%) | $26.19 M(+19.1%) |
| Sept 2008 | - | $21.98 M(+0.8%) |
| June 2008 | - | $21.81 M(-1.5%) |
| Mar 2008 | - | $22.14 M(-3.1%) |
| Dec 2007 | $22.84 M(-21.5%) | $22.84 M(-1.2%) |
| Sept 2007 | - | $23.12 M(-13.5%) |
| June 2007 | - | $26.71 M(-8.0%) |
| Mar 2007 | - | $29.04 M(-0.2%) |
| Dec 2006 | $29.09 M(+6.5%) | $29.09 M(-17.1%) |
| Sept 2006 | - | $35.08 M(-1.8%) |
| June 2006 | - | $35.73 M(-7.2%) |
| Mar 2006 | - | $38.50 M(+41.0%) |
| Dec 2005 | $27.31 M(+191.5%) | $27.31 M(+123.7%) |
| Sept 2005 | - | $12.21 M(-28.6%) |
| June 2005 | - | $17.11 M(+85.8%) |
| Mar 2005 | - | $9.21 M(-1.7%) |
| Dec 2004 | $9.37 M(+7.8%) | $9.37 M(-2.7%) |
| Sept 2004 | - | $9.63 M(-35.9%) |
| June 2004 | - | $15.04 M(+70.2%) |
| Mar 2004 | - | $8.83 M(+1.6%) |
| Dec 2003 | $8.70 M(-16.3%) | $8.70 M(-4.1%) |
| Sept 2003 | - | $9.07 M(-3.5%) |
| June 2003 | - | $9.40 M(-5.3%) |
| Mar 2003 | - | $9.93 M(-4.5%) |
| Dec 2002 | $10.39 M(+267.8%) | $10.39 M(+4.2%) |
| Sept 2002 | - | $9.97 M(+319.9%) |
| June 2002 | - | $2.38 M(-9.6%) |
| Mar 2002 | - | $2.63 M(-7.0%) |
| Dec 2001 | $2.83 M(+94.2%) | $2.83 M(+147.5%) |
| Sept 2001 | - | $1.14 M(-8.4%) |
| June 2001 | - | $1.25 M |
| Dec 2000 | $1.46 M(>+9900.0%) | - |
| Dec 1999 | $0.00(-100.0%) | - |
| Dec 1998 | $209.00 K | - |
FAQ
- What is Plus Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly long term liabilities year-on-year change?
What is Plus Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PSTV is $2.01 M
What is the all time high annual total long term liabilities for Plus Therapeutics?
Plus Therapeutics all-time high annual total long term liabilities is $33.77 M
What is Plus Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PSTV is $40.00 K
What is the all time high quarterly long term liabilities for Plus Therapeutics?
Plus Therapeutics all-time high quarterly total long term liabilities is $41.54 M
What is Plus Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PSTV quarterly total long term liabilities has changed by -$1.97 M (-98.01%)